New Cystic Fibrosis Drug Brings Gift of a Future, NPR Reports Online
| 1 min read

In her entire 41 years, Roe Van Epps had never been able to shovel snow because of the crippling effect of cystic fibrosis. Then came the experimental CF drug VX-770 and one day this winter following a blizzard, she cleared her entire driveway. 
Her inspiring story, and the scientific road traveled by the CF Foundation and Vertex Pharmaceuticals to develop VX-770, is featured in a National Public Radio story today, in a blog called CommonHealth.
NPR chronicles the Foundation's successful approach to drug development. “The Cystic Fibrosis Foundation, founded in 1955, is held up by many as a model disease-fighting group that bridges between researchers, doctors, patients and donors in perpetual quest for a cure,” the story says, continuing: “Without the Foundation, everyone seems to agree, there would be no VX-770.”
Read the full NPR story about VX-770.

Share this article
About the CF Foundation | CFTR Modulators | Our Research Approach
Recent news
CF Foundation Grateful for Continued Access to Trikafta in Colorado After Prescription Drug Affordability Board’s Ruling
News | 2 min read
CF Foundation Invests Up to $3 Million in ViaNautis Bio to Explore a New Method to Deliver Genetic Therapies to People With CF
News | 2 min read
CF Foundation Formalizes Final Set of Recommendations From External Racial Justice Working Group
News | 4 min read
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.